Swedish Esophageal and Cardia Cancer Study
NCT06031155 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 616
Last updated 2023-09-11
Summary
The overall objective of this nationwide Swedish project is to identify strategies that can help reduce the suffering and improve the survivorship among patients surgically treated for oesophageal cancer. This objective can be accomplished by a broad research approach that aims to:
1. describe health-related quality of life (HRQL)
2. identify risk factors and preventive actions for poor HRQL
Conditions
- Oesophageal Cancer
- Surgery
- Survivorship
- Quality of Life
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Pernilla Lagergren, PhD · Karolinska Institutet
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-04-30
- Primary Completion
- 2025-12-31
- Completion
- 2025-12-31
More Related Trials
-
Health-related Quality of Life of Patients With Esophageal Cancer After Surgery
NCT01349517 ·Status: UNKNOWN ·Phase: PHASE2
-
Tislelizumab Combined With Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma Followed by CRT or Surgery
NCT07046221 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Genetic and Environmental Risk Factors Related to Esophageal Cancer
NCT01035398 ·Status: ACTIVE_NOT_RECRUITING
-
Discovering Patterns in Experiences of Patients in Esophageal Cancer Clinical Research
NCT05831150 ·Status: NOT_YET_RECRUITING
-
Effects of a Training Intervention After Thoracoabdominal Oesophagus Surgery
NCT02335970 ·Status: COMPLETED ·Phase: NA
-
Docetaxel and S-1 for Advanced Esophageal Cancer
NCT01693432 ·Status: UNKNOWN ·Phase: PHASE2
-
Quality Of Life Outcomes Following Treatment for Esophageal Cancer
NCT00598117 ·Status: COMPLETED
-
Textbook Outcomes After Oesophagectomy in Regional Australia
NCT06721715 ·Status: NOT_YET_RECRUITING
-
Predicting Postoperative Chemotherapy Efficacy in Patients With Esophageal Squamous Cell Carcinoma
NCT06490003 ·Status: RECRUITING
-
Organ Preservation With Durvalumab-based Immunotherapy in Combination With Chemoradiation as Definitive Therapy for Early Stage Esophageal Adenocarcinoma With Indication for Radical Surgery
NCT05713838 ·Status: RECRUITING ·Phase: PHASE2
-
Surgery or Chemoradiotherapy for Cervical Esophageal Cancer
NCT05327517 ·Status: RECRUITING ·Phase: NA
-
The Effect of exeRcise And Diet on Quality of Life in Patients With Incurable Cancer of Esophagus and Stomach (RADICES)
NCT06138223 ·Status: RECRUITING ·Phase: NA
-
Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer
NCT00072033 ·Status: COMPLETED ·Phase: PHASE2
-
Quality of Life Assessment of Patients Receiving Treatment for Esophageal Cancer [Companion to CALGB-9781]
NCT00003381 ·Status: TERMINATED
-
Combination Chemotherapy Plus Radiation Therapy Followed By Surgery in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer
NCT00006472 ·Status: TERMINATED ·Phase: PHASE2
-
Induction Tislelizumab Combined With Chemotherapy Followed by Definitive Chemoradiotherapy in the Treatment of Locally Unresectable Esophageal Squamous Cell Carcinoma
NCT05515315 ·Status: RECRUITING ·Phase: PHASE2
-
Local Therapy for Oligorecurrent and Oligometastatic Esophageal Squamous Cell Carcinoma
NCT03904927 ·Status: COMPLETED ·Phase: PHASE2
-
Tislelizumab Combined with Chemotherapy and All Trans Retinoic Acid for Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma
NCT06703047 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Neoadjuvant Therapy for Esophageal Cancer and Cardiopulmonary Physiology
NCT03462524 ·Status: COMPLETED
-
Timing of Resective Surgery After Neoadjuvant Chemoradiotherapy in Esophageal Cancer
NCT02415101 ·Status: COMPLETED ·Phase: NA
-
Induction Chemotherapy for Locally Advanced Esophageal Cancer
NCT03110926 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
RCT on the Combined Modality Treatment of Squamous Cell Carcinoma of the Esophagus
NCT00559351 ·Status: TERMINATED ·Phase: PHASE3
-
Identification of Individual Histological and Blood Markers in Patients With Recurrent or Metastatic Upper Aerodigestive Tract Squamous Cell Carcinoma in Response to Immunotherapies
NCT06061705 ·Status: RECRUITING ·Phase: NA
-
Chemotherapy With or Without Surgical Resection in Locally Advanced Esophageal Cancer
NCT00193141 ·Status: COMPLETED ·Phase: PHASE2
-
Perioperative Vs. Preoperative Chemotherapy With Surgery in the Squamous Carcinoma of Esophagus
NCT01225523 ·Status: COMPLETED ·Phase: PHASE1